Oxidative stress is increasingly recognized as a key mechanism in the biotransformation and/or toxicity of many xenobiotics. Human arylamine N-acetyltransferase 1 (NAT1) is a polymorphic ubiquitous phase II xenobiotic metabolizing enzyme that catalyzes the biotransformation of primary aromatic amine or hydrazine drugs and carcinogens. Functional and structural studies have shown that NAT1 catalytic activity is based on a cysteine protease-like catalytic triad, containing a reactive cysteine residue. Reactive protein cysteine residues are highly susceptible to oxidation by hydrogen peroxide (H 2 O 2 ) generated within the cell. We, therefore, investigated whether human NAT1 activity was regulated by this cellular oxidant. Using purified recombinant NAT1, we show here that NAT1 is rapidly (k inact ‫؍‬ 420 M ؊1 ⅐min ؊1 ) inactivated by physiological concentrations of H 2 O 2 . Reducing agents, such as reduced glutathione (GSH), reverse the H 2 O 2 -dependent inactivation of NAT1. Kinetic analysis and protection experiments with acetyl-CoA, the physiological acetyl-donor substrate of the enzyme, suggested that the H 2 O 2 -dependent inactivation reaction targets the active-site cysteine residue. Finally, we show that the reversible inactivation of NAT1 by H 2 O 2 is due to the formation of a stable sulfenic acid group at the active-site cysteine. Our results suggest that, in addition to known genetically controlled interindividual variations in NAT1 activity, oxidative stress and cellular redox status may also regulate NAT1 activity. This may have important consequences with regard to drug biotransformation and cancer risk.
ine N-acetyltransferases (NATs; EC 2.3.1.5) are phase II XME that catalyze the transfer of an acetyl moiety from acetyl-CoA to the nitrogen or oxygen atom of primary arylamines, hydrazines, and their N-hydroxylated metabolites (2) . NATs, therefore, play an important role in the detoxification and/or activation of substrates, including arylamine drugs and carcinogens (3, 4) . NAT enzymes have been identified in several species (5) (6) (7) (8) . In humans, two functional isoforms of NATs (NAT1 and NAT2) have been described (9) . Interindividual genetic variations in their genes have been shown to cause differences in NAT1 and NAT2 protein levels and activity. These variations are a potential source of pharmacological and/or pathological susceptibility (4, 10, 11) . Although the human NAT1 and NAT2 protein sequences are 81% identical (12) , their kinetic selectivity for amine-containing acceptor substrates differs markedly (13) . The tissue distributions of these two enzymes also differ, with NAT2 present principally in the liver and intestinal epithelium and NAT1 being ubiquitous (2, 11) . Elucidation of the crystal structures of NATs from Salmonella typhimurium and Mycobacterium smegmatis and homology models of the two human NATs have revealed structural similarity to cysteine proteases and the existence of a conserved cysteine protease-like catalytic triad (Cys-His-Asp) in the catalytic core of NATs (14 -17) . These structural data show that vertebrate and eubacterial NATs have adapted a catalytic mechanism commonly found in cysteine proteases for use in acetyl-transfer reactions (2, 14, 15) .
Redox-dependent regulation of catalytic activities by reversible oxidation of an active-site cysteine residue has been reported for several enzymes, including protein phosphatases (18 -21) and cysteine proteases (22) (23) (24) . H 2 O 2 is one of the oxidants that has been shown to regulate cell function, by oxidizing active cysteine residues in proteins to cysteine sulfenic acid or to disulfide (20, (25) (26) (27) . In vivo, H 2 O 2 formation is mainly due to enzymatic reactions such as the superoxide dismutase-dependent dismutation of superoxide (26, 28, 29) . Although superoxide can oxidize proteins (30) , H 2 O 2 , its main product, has appeared as a critical element involved in many cellular functions, including cell signaling (20, 27, 28, 31) . In addition, substantial increases in the intracellular concentration of H 2 O 2 are generally associated with deleterious conditions such as apoptosis, necrosis, inflammation, and cancer (20, 26, 27, 31) . The induction of H 2 O 2 production by xenobiotics has also been described, with potential effects on cys-* This work was supported by the Association pour la Recherche sur le Cancer and by Association Francaise contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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teine-containing proteins (32) (33) (34) (35) . Redox-dependent detoxification and/or activation of xenobiotics also suggests that cellular redox conditions may affect XME-dependent biotransformations (35) (36) (37) (38) . We investigated here whether the catalytic activity of human NAT1 was regulated by H 2 O 2 . We found that NAT1 activity was reversibly inhibited by physiologically relevant concentrations of H 2 O 2 . We demonstrate that H 2 O 2 oxidized rapidly NAT1, leading to oxidative inactivation of the enzyme. This H 2 O 2 -dependent inactivation of NAT1 probably results from oxidative modification of the essential catalytic cysteine residue to a stabilized cysteine sulfenic acid, as shown for other enzymes (39 -41) . The inactivated NAT1 was reactivated by physiological thiols, such as reduced glutathione. Our results suggest that in addition to the polymorphic-dependent variation of NAT1 activity, H 2 O 2 and, more broadly, cellular redox status, could also regulate NAT1 activity, which may have important consequences with regard to drug toxicity and cancer risk.
EXPERIMENTAL PROCEDURES
Materials-p-Aminosalicylic acid (PAS, a NAT1-selective arylamine acceptor substrate), p-nitrophenylacetate (PNPA, acetyl donor), acetylcoenzyme A (AcCoA, acetyl donor), coenzyme A (CoA), hydrogen peroxide (H 2 O 2 ), 5,5-dimethyl-1,3-cyclohexanedione (dimedone), 1,4-dithiothreitol (DTT), reduced glutathione (GSH), imidazole, lysozyme and glutathione-agarose, bovine catalase (5200 units/mg), glucose oxidase (type II from Aspergillus niger, 15,500 units/g), and ␤-D-glucose were purchased from Sigma. PGEX-2T vector and Escherichia coli BL21(DE3) cells were supplied by Amersham Biosciences. The pET28 vector was obtained from Novagen. Nickel-nitrilotriacetic acid superflow resin was purchased from Qiagen. Anti-fluorescein FabЈ fragments conjugated to peroxidase, fluorescein-conjugated iodoacetamide, and complete protease inhibitor tablets were obtained from Roche Applied Science. All other reagents were obtained from Sigma or Eurobio (Les Ulis, France). The Bradford protein assay kit was purchased from Bio-Rad.
Expression and Purification of Recombinant Human NAT1-The human NAT1 cDNA, kindly provided by Dr. D. Grant (Toronto, Canada), was subcloned into pGEX-2T and pET28 vectors. The resulting constructs encoded the enzyme as a glutathione S-transferase fusion protein (GST-NAT1) and as a polyhistidine-tagged fusion protein (His-NAT1), respectively. We transformed BL21(DE3) bacteria with these constructs, induced expression of the transgene with 0.1 mM isopropyl-1-thio-␤-D-galactopyranoside, and cultured the cells for 4 h at 37°C. Bacteria were pelleted by centrifugation (6,000 ϫ g, 30 min), washed with cold phosphate-buffered saline, and harvested by centrifugation (6,000 ϫ g, 30 min). Pellets were stored at Ϫ80°C until required.
For the purification of recombinant proteins, pellets (from 1-liter cultures) were resuspended in 40 ml of 50 mM Tris-HCl, pH 8, 150 mM NaCl (lysis buffer) containing lysozyme (1 mg/ml final concentration) and protease inhibitors. Following incubation (1 h at 4°C), protease inhibitors, DNase I (20 g/ml final concentration), and 0.2% Triton X-100 (final concentration) were added, and the suspension was incubated for an additional hour at 4°C. Lysates were then subjected to sonication on ice (five pulses of 10 s each), centrifuged (12,000 ϫ g, 30 min), and the supernatant collected.
For the purification of GST-NAT1, this supernatant was added to glutathione-agarose beads (40 mg/liter of original culture) for 2 h at 4°C. Beads were then poured into a column and washed successively with 5 volumes of lysis buffer containing 0.2% Triton X-100 followed by 5 volumes of lysis buffer alone. GST-NAT1 was then eluted with 10 mM reduced glutathione (final) in 50 mM Tris-HCl, pH 8, 1 mM EDTA. The purified enzyme was reduced by incubation with 10 mM DTT (final concentration) for 10 min at 4°C and was then dialyzed against 25 mM Tris-HCl, pH 7.5, 1 mM EDTA.
The His-NAT1 protein was prepared in a similar manner to GST-NAT1. Briefly, supernatants from bacterial lysates were incubated with 1.5 ml of nickel-nitrilotriacetic acid Superflow resin in the presence of 20 mM imidazole (final concentration) for 2 h at 4°C. The resin was then poured into a column and washed successively with lysis buffer containing 0.2% Triton X-100 and lysis buffer containing 50 mM imidazole (final concentration). His-NAT1 was eluted with 300 mM imidazole (final concentration) in lysis buffer. Purified His-NAT1 was reduced by incubation with 10 mM DTT (final concentration) for 10 min at 4°C and was then dialyzed against 25 mM Tris-HCl, pH 7.5, 1 mM EDTA.
SDS-PAGE analysis was carried out at each stage of purification, and protein concentrations were determined using a standard Bradford assay.
Recombinant-tagged NAT1 enzyme was used in a previous study for functional characterization of the NAT1 enzyme (42) . In this study, we used both GST-NAT1 and His-NAT1 as sources of purified recombinant NAT1 enzyme, and similar results were obtained with both proteins in all experiments.
Enzyme Assays-NAT1 enzyme activity was determined spectrophotometrically (410 nm), using PNPA as the acetyl donor and PAS as the NAT1-specific arylamine substrate, as described by Mushtaq et al. (43) . Briefly, treated or non-treated samples (10 -20 l) containing NAT1 enzyme were assayed in a reaction mixture containing 500 M PAS (final concentration) in 25 mM Tris-HCl, pH 7.5, 1 mM EDTA. Reactions were started by adding 125 M PNPA (final concentration). In all reaction mixtures (total volume of 1 ml), the final concentration of NAT1 was 15 nM. The reaction mixture was incubated for 10 min incubation at 37°C, and the reaction was then quenched by adding SDS (1% final concentration). p-Nitrophenol, generated by the NAT1-mediated hydrolysis of PNPA in the presence of PAS, was quantified by measuring absorbance at 410 nm with an enzyme-linked immunosorbent assay plate analyzer (Metertech). One unit of enzyme was defined as the amount of enzyme giving an A 410 value of 0.5 per 10 min per ml. For the controls, we omitted the enzyme, PNPA, or PAS. All enzyme reactions were performed in quadruplicate, in conditions in which the initial rates were linear. Enzyme activities are shown as percentages of control NAT1 activity.
Reaction ). In all subsequent experiments, the final concentration of enzyme during the oxidation step with H 2 O 2 was 1.5 M, giving a final concentration in the enzyme assay of 15 nM. The total volume of the enzyme assay (1 ml) provided a great enough dilution (1:50 or 1:100) of the various compounds used to prevent these compounds from interfering with NAT1 enzyme activity measurements. NAT1 activity in the absence of H 2 O 2 was taken as 100% activity (control).
We assessed the effect of bolus addition of H 2 O 2 on NAT1 enzyme activity by incubating purified NAT1 samples (1.5 M final concentration) with various concentrations of H 2 O 2 in 25 mM Tris-HCl, pH 7.5, 1 mM EDTA (total volume of 10 l) for 10 min at 37°C. Mixtures were then assayed for NAT1 activity, as described above.
In reactivation experiments, NAT1 (1.5 M final concentration) was first oxidized by H 2 O 2 (200 M final concentration), as described above, and incubated with catalase (300 unit/ml) for 1 min at 37°C. The mixture was then incubated for 10 min at 37°C with various concentrations of DTT or GSH in a total volume of 20 l. A NAT1 enzyme assay was then carried out. Assays performed in this conditions (with catalase) but without H 2 O 2 gave 100% NAT1 activity.
In substrate protection experiments, NAT1 (1.5 M final concentration) was first incubated with various concentrations of AcCoA or CoA (final concentrations of 0.4 -4 mM) in 25 mM Tris-HCl, pH 7.5, 1 mM EDTA (total volume of 10 l) for 5 min at 37°C. Samples were then incubated with H 2 O 2 (200 M final concentration) in a total volume of 20 l, as described above, and assayed. Assays performed in these conditions with AcCoA or CoA alone gave 100% NAT1 activity.
In dimedone assays, NAT1 (1.5 M final concentration) was first incubated with H 2 O 2 (200 M final concentration) in the presence of 10 mM dimedone (a specific reagent of sulfenic acid) in 25 mM Tris-HCl, pH 7.5, 1 mM EDTA (10 l total volume) for 10 min at 37°C. It was then incubated with DTT (5 mM final concentration, 20 l total volume) for 10 min at 37°C. Residual NAT1 activity was assayed as described above. Assays performed in these conditions, with dimedone alone (10 mM final concentration) gave 100% NAT1 activity. (44, 45) . Quantification of H 2 O 2 generated by 0.15 unit/ml of glucose oxidase was determined by measuring the absorbance at 240 nm, and the peroxidase/o-phenylenediamine dihydrochloride assay as described elsewhere (44, 46) . We assessed the effect of continuous generation of H 2 O 2 by glucose oxidase by incubating purified NAT1 (1.5 M) with glucose oxidase (0.15 unit/ml) and glucose (5 mM) in 25 mM Tris-HCl, pH 7.5, 1 mM EDTA (total volume of 15 l) at 37°C. At various time intervals, catalase (300 units/ml) was added prior to NAT1 residual activity measurements. Controls where catalase was added to the glucose/glucose oxidase system were carried out. In addition, controls without glucose oxidase, without glucose, and without catalase were also done. Assays were all done in quaduplicate. H 2 O 2 constant production rate in these experiments was determined to be Ϸ6 M H 2 O 2 /min.
Fluorescein-conjugated Iodoacetamide Labeling of Proteins-Purified NAT1 (1.5 M final concentration) was preincubated with or without (control) various concentrations of H 2 O 2 (final concentration from 50 to 400 M) in 25 mM Tris-HCl, pH 7.5, 1 mM EDTA for 10 min at 37°C. Samples were then incubated with fluorescein-conjugated iodoacetamide (20 M final concentration) for 10 min at 37°C. Samples were then analyzed by SDS-PAGE under reducing conditions followed by Western blotting, using anti-fluorescein FabЈ fragments conjugated to peroxidase.
Statistical Analysis-Results are expressed as means Ϯ S.D. of three independent experiments performed in quadruplicate, unless otherwise stated. We used Student's t test, as appropriate, with levels of significance set at p Ͻ 0.05 (*) or p Ͻ 0.01 (**).
Protein Determination, SDS-PAGE, and Western Blotting-Protein concentrations were determined using a Bradford assay (Bio-Rad). Samples were combined with reducing 4 ϫ SDS sample buffer and separated by SDS-PAGE. Gels were stained with Coomassie Brilliant Blue R-250. For Western blotting, following separation by SDS-PAGE, proteins were electrotransferred onto nitrocellulose membrane. The membrane was blocked by incubation with Tris-buffered saline/Tween 20 (TBS) containing 5% nonfat milk powder for 1 h. Anti-fluorescein FabЈ fragments conjugated to horseradish peroxidase (1:100,000) was added and the membrane incubated for 1 h in TBS. The membrane was washed and incubated with Supersignal reagent (Pierce) for detection. (Fig. 1A) . At a concentration of 200 M, H 2 O 2 inhibited the enzyme by over 90%. An IC 50 of 45 M was obtained for an enzyme concentration of 1.5 M. To make a more realistic and physiologic assessment of the effect of H 2 O 2 on NAT1 activity, we used another source of H 2 O 2 , the steady conversion of ␤-D-glucose to D-gluconolactone and H 2 O 2 , which is catalyzed by glucose oxidase (45) . As shown in Fig. 1B (filled  circles) , NAT1 (1.5 M final) was also inactivated by the constant production of H 2 O 2 through the glucose/glucose oxidase system. In the conditions used, the constant production rate of H 2 O 2 was estimated to be Ϸ6 M H 2 O 2 /min, which is physiologically relevant (45, 51) . After a 15-min incubation, residual NAT1 activity was close to 30% of the control. After a 30-min exposure to H 2 O 2 , the residual activity was less than 10%. No inactivation of NAT1 by H 2 O 2 generated by the glucose/glucose oxidase system was observed in presence of catalase (300 units/ ml) (Fig. 1B, open circles) . Thus, these experiments suggest that NAT1 enzyme is inactivated by bolus addition and constant generation of physiologically relevant levels of H 2 O 2 .
RESULTS

In Vitro Inactivation of NAT1 by Bolus
Detection of H 2 O 2 -oxidized Cysteine Residues by Labeling with Fluorescein-conjugated
Iodoacetamide-We investigated whether NAT1 contained reactive cysteine residues susceptible to oxidation by physiological concentrations of H 2 O 2 , using an approach based on the labeling of cysteine with 5-iodoacetamidofluorescein (25) . Incubation of NAT1 with various concentrations of H 2 O 2 resulted in the dose-dependent modification of cysteine residues, as indicated by the disappearance of fluorescein-conjugated iodoacetamide labeling (Fig. 2) . Thus, NAT1 cysteine residues are modified by H 2 O 2 .
Reactivation of H 2 O 2 -inactivated NAT1 by Thiol-reducing Agents-We investigated whether the H 2 O 2 -dependent inactivation of NAT1 could be reversed by thiol-reducing agents, as reported for other enzymes (18 -20, 23) . NAT1 (1.5 M final concentration) was first inactivated by incubation with H 2 O 2 (200 M final concentration), and excess H 2 O 2 was removed by catalase (300 units/ml). Inactivated NAT1 was then incubated with DTT or GSH, at various concentrations (1, 5, or 10 mM final concentration), and NAT1 activity was determined (Fig.  3) . Both DTT and GSH reactivated H 2 O 2 -inactivated NAT1 (Fig. 3) . At a concentration of 5 mM DTT, the H 2 O 2 -dependent inactivation of NAT1 was completely reversed. In contrast, 5 mM GSH gave Ϸ60% of the NAT1 control activity. A final concentration of 10 mM GSH was able to recover Ϸ100% of the original NAT1 activity. Thus, the H 2 O 2 -dependent inactivation of NAT1 is reversible. Our results also suggest that the H 2 O 2 -inactivated NAT1 enzyme could be reactivated by GSH.
Inhibition Kinetics and Stoichiometry-We carried out kinetic analysis of the H 2 O 2 -dependent inactivation of NAT1 in the presence or absence of various concentrations of H 2 O 2 . Semilogarithmic plots of percent residual activity versus time for various concentrations of H 2 O 2 gave straight lines, indicating that inactivation obeyed apparent first-order reaction (Fig.  4A) . Replotting the observed pseudo-first-order rate constants (k obs ) against H 2 O 2 concentrations gave a straight line that passed very close to the origin (Fig. 4B) , consistent with a single-step reaction in which the reverse rate (obtained from the y intercept) was close to zero. n , where n is the order of H 2 O 2 in its reaction with NAT1. Thus, replotting ln of k obs versus ln of H 2 O 2 concentration gave a straight line (Fig. 4C) . The slope was n ϭ 0.87, indicating that the inactivation of NAT1 by H 2 O 2 involved 1:1 stoichiometry. Thus, the oxidative inactivation of NAT1 by H 2 O 2 is a rapid bimolecular process in which one molecule of H 2 O 2 modifies the catalytic cysteine residue, leading to inactivation of the enzyme.
Identification of the Site Modified by H 2 O 2 during NAT1 Inactivation-We then investigated whether the active-site cysteine of NAT1 was the target of H 2 O 2 -dependent oxidative inactivation. We included AcCoA (physiological acetyl-donor substrate of NAT1), which forms a covalent acetyl-enzyme intermediate (49) , in the reaction to provide protection from inactivation by H 2 O 2 . CoA, a product of AcCoA hydrolysis that does not form an acetyl-enzyme intermediate, was used as a control. AcCoA conferred dose-dependent protection (up to 64) of NAT1 from H 2 O 2 -induced inactivation, whereas CoA did not (Table I) . Of the five cysteine residues present in NAT1, only the active site cysteine has been shown to be conserved in all known NAT sequences and to be critical for enzyme function (5, 7, 48) . Although we cannot rule out the possibility that H 2 O 2 modifies other cysteine residues of NAT1, these results clearly demonstrate that the catalytic active site cysteine residue of NAT1 is a target of H 2 O 2 -dependent oxidative modification, leading to reversible inactivation of the enzyme.
Determination of the Chemical Nature of the H 2 O 2 -oxidized Active-site Cysteine of NAT1-The results reported above led us to investigate the chemical nature of the H 2 O 2 -modified catalytic cysteine of the NAT1 enzyme. As H 2 O 2 -dependent oxidative inactivation of NAT1 was fully reversible, the oxidized active site cysteine was unlikely to be in the form of a sulfinic (-SO 2 H) or sulfonic acid (-SO 3 H), neither of which could be reduced by thiol-reducing agents (27, 40) . There were two other possibilities. The active-site cysteine residue of the H 2 O 2 -inactivated enzyme may be involved in an inter-or intramolecular disulfide bond or form a stable cysteine sulfenic acid (-SOH), any of which could be reduced to give cysteine. Intermolecular and intramolecular disulfide bonds were ruled out on the basis of electrophoretic mobility shift assays (54) . In addition, the catalytic cysteine residue of human NAT1 has been predicted to be at the base of the active-site pocket and inaccessible to other cysteine residues within the same molecule (15) . Dimedone has been shown to react specifically with sulfenic acids to form a stable thioether product that cannot be reduced by thiol-reducing agents (22) . This compound has been shown to identify cysteine sulfenic acids at the active sites of various enzymes (22, 55, 56) . We investigated whether the H 2 O 2 -dependent inactivation of NAT1 resulted from the formation of a stable sulfenic acid at the active site cysteine by incubating dimedone (10 mM final concentration) with H 2 O 2 -oxidized NAT1 (Fig. 5) . The control, in which NAT1 was incubated with 10 mM dimedone alone, showed no inhibition of activity (data not shown). The enzymatic activity of the NAT1 sample treated with H 2 O 2 alone was fully restored by incubation with 5 mM DTT (final concentration). In contrast, NAT1 cotreated with H 2 O 2 and dimedone was only partially reactivated (63% of control activity), consistent with the formation of a stable sulfenic acid at the active site cysteine. The partial, but significant, effect of dimedone on H 2 O 2 -treated NAT1 was probably due to the low reactivity of dimedone with sulfenic acids. This partial effect of dimedone has been reported elsewhere for incubations for short periods of time (Ͻ1 h) at a final concentration of 10 mM (22, 56) . DISCUSSION H 2 O 2 has been shown to inactivate reversibly reactive cysteine-containing enzymes, such as phosphatases, both in vitro and in vivo (20) .
We provide here chemical and kinetic evidence to support that human NAT1 activity is regulated by H 2 O 2 . Human NAT1 activity was significantly inactivated by both the bolus addition and the constant generation of physiologically relevant levels of H 2 O 2 as reported, in similar conditions, for certain proteintyrosine phosphatases (PTPs), in particular the isoform 1B (PTP1B) (18, 20, 57) . Indeed, in experimental conditions similar to ours (similar enzyme and H 2 O 2 concentrations, incubation times), IC 50 values ranging from 60 to 100 M were reported for inactivation of these PTPs by H 2 O 2 (18, 20, 57) . These values are very close to the IC 50 determined for the inactivation of NAT1 by H 2 O 2 (IC 50 ϭ 45 M). Moreover, kinetic analysis showed the rapid oxidation of NAT1 by H 2 O 2 , with a second-order rate constant (k inact ) for enzyme inactivation of 420 M Ϫ1 ⅐min Ϫ1 (Fig. 5) . Interestingly, this value is, again, very close to the k inact constants (Ϸ600 M Ϫ1 ⅐min Ϫ1 ) reported for the PTPs mentioned above, the activities of which are regulated in vivo by H 2 O 2 (18, 19, 57) . Similar k inact values were also obtained for caspase 3, a redox-regulated cysteine protease involved in apoptosis (23, 24) . The inactivation of NAT1 by H 2 O 2 was fully reversed by the non physiological thiol reductant DTT and by physiological concentrations of GSH, showing that H 2 O 2 -dependent inactivation of NAT1 is reversible. In contrast, physiological concentrations (up to 10 mM) of oxidized glutathione (GSSG) had no effect on NAT1 activity, suggesting that GSSG is unlikely to regulate NAT1 activity in vivo. GSH, a cellular reductant, is 
the major determinant of cellular redox potential, with a concentration of 1-10 mM (52, 53) . Thus, our results suggest that GSH could reactivate H 2 O 2 -inactivated NAT1 in the cell. GSH levels can be decreased by oxidative stress, in particular by xeniobiotic-induced oxidative stress, with potential effects on the biotransformation activity of the phase II XME glutathione S-transferase (35) . Our findings are consistent with the specific oxidation of cysteine or methionine residues. Kinetic analysis (Fig. 5C ) and protection experiments with AcCoA clearly showed that the essential active-site cysteine of NAT1 was the specific target of H 2 O 2 -dependent inactivation and that cysteine thiolate was the reactive species. Thiolates are much more susceptible to oxidation by H 2 O 2 in cells than other protein cysteine residues as they are intrinsically stronger nucleophiles (19, 20, 58) . Enzymes that contain an essential thiolate in their active site are widely accepted to be potential candidates for reversible oxidation by H 2 O 2 generated within the cell (20, 25, 31) . For instance, PTP1B, a phosphatase mentioned above, has been shown to be reversibly inactivated in vitro and in vivo by H 2 O 2 , via oxidation of its catalytic cysteine residue (18, 57) . H 2 O 2 can oxidize cysteine residues in proteins to give cysteine sulfenic acid or disulfide, which can be reduced back to cysteine by cellular reductants, such as GSH (19, 20) . We provide strong evidence that the H 2 O 2 -dependent inactivation of NAT1 involved the formation of a stable sulfenic acid at the active-site cysteine (Cys-SOH) of the enzyme. Interest in this oxidative modification of cysteine residues has increased, since it was shown to play an important role in redox-regulated processes (41) . More specifically, the formation of stable sulfenic acid at the active-site cysteine of various enzymes, such as tyrosine phosphatase and glutathione reductases, has been suggested to play a key role in the reversible inhibition of these enzymes during oxidative or nitrosative stress (39, 40) . The stability of Cys-SOH in proteins depends mainly on the presence of an apolar microenvironment around the Cys-SOH and the absence of proximal cysteine residues (39) . Interestingly, the active-site pocket of NAT enzymes, and more specifically human NAT1 and NAT2, has been reported to be apolar with no other cysteine residue being proximal to the catalytic cysteine of these enzymes (2, 8, 15, 16, 59) . Thus, the formation of a stable sulfenic acid at the active-site cysteine residue seems to be a plausible mechanism for the reversible inactivation of human NAT1 by H 2 O 2 . Conversely, formation of an inter-or intramolecular disulfide formation similar to that observed in some H 2 O 2 -regulated proteins (18, 60) is unlikely. First, in NAT family, only the catalytic cysteine is absolutely conserved. Second, the catalytic cysteine residue of human NAT1 is buried at the base of the active-site pocket with no other proximal cysteine residue (15) . Third, no electrophoretic mobility shifts were observed between reduced and H 2 O 2 -oxidized NAT1 (data not shown). Finally, dimedone experiments demonstrated the presence of a stable sulfenic acid after H 2 O 2 inactivation.
Our results suggest that human NAT1 could be reversibly inactivated in vivo by H 2 O 2 , as shown for other enzymes such as PTPs. Given the importance of oxidative stress in the biotransformation and/or toxicity of many xenobiotics, the inactivation of human NAT1 by H 2 O 2 may be of physiological significance. Our data suggest that, in addition to polymorphic variation of the NAT1 gene (61) , redox conditions could regulate NAT1 functional activity. This supports recent reports (62, 63) suggesting that non-genetic factors, such as substrate-dependent inhibition, may also contribute to overall NAT1 activity.
